TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
22 hedge funds and large institutions have $14.4M invested in Trillium Therapeutics Inc. in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$174K | |
| 2 | +$143K | |
| 3 | +$137K | |
| 4 |
NLVP
New Leaf Venture Partners
New York
|
+$45.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$27.7K |
Top Sellers
| 1 | -$622K | |
| 2 | -$470K | |
| 3 | -$168K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$143K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$139K |